ARS Pharmaceuticals Down over 24%, on Track for Largest Percent Decrease Since September 2023

Dow Jones06-26

ARS Pharmaceuticals, Inc. $(SPRY)$ is currently at $7.93, down $2.61 or 24.76%

 

--Would be lowest close since May 20, 2026, when it closed at $7.80

--On pace for largest percent decrease since Sept. 20, 2023, when it fell 55.79%

--Snaps a three day winning streak

--Down 12.57% month-to-date; on pace for worst month since March 2026, when it fell 13.47%

--Down 31.93% year-to-date

--Down 86.87% from its all-time closing high of $60.41 on March 17, 2021

--Down 56.14% from 52 weeks ago (June 26, 2025), when it closed at $18.08

--Down 56.78% from its 52-week closing high of $18.35 on July 28, 2025

--Up 17.83% from its 52-week closing low of $6.73 on Nov. 20, 2025

--Traded as low as $7.50; lowest intraday level since May 20, 2026, when it hit $7.19

--Down 28.84% at today's intraday low; largest intraday percent decrease since Sept. 20, 2023, when it fell as much as 61.39%

 

All data as of 3:01:34 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 25, 2026 15:03 ET (19:03 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment